Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): Explanation and elaboration

A. Cecile J.W. Janssens; John P.A. Ioannidis; Sara Bedrosian; Paolo Boffetta; Siobhan M. Dolan; Nicole Dowling; Isabel Fortier; Andrew N. Freedman; Jeremy M. Grimshaw; Jeffrey Gulcher; Marta Gwinn; Mark A. Hlatky; Holly Janes; Peter Kraft; Stephanie Melillo; Christopher J. O'Donnell; Michael J. Pencina; David Ransohoff; Sheri D. Schully; Daniela Seminara; Deborah M. Winn; Caroline F. Wright; Cornelia M. Van Duijn; Julian Little; Muin J. Khoury

doi:10.1016/j.jclinepi.2011.02.003

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): Explanation and elaboration

A. Cecile J.W. Janssens, John P.A. Ioannidis, Sara Bedrosian, Paolo Boffetta, Siobhan M. Dolan, Nicole Dowling, Isabel Fortier, Andrew N. Freedman, Jeremy M. Grimshaw, Jeffrey Gulcher, Marta Gwinn, Mark A. Hlatky, Holly Janes, Peter Kraft, Stephanie Melillo, Christopher J. O'Donnell, Michael J. Pencina, David Ransohoff, Sheri D. Schully, Daniela SeminaraDeborah M. Winn, Caroline F. Wright, Cornelia M. Van Duijn, Julian Little, Muin J. Khoury

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	e1-e22
Journal	Journal of Clinical Epidemiology
Volume	64
Issue number	8
DOIs	https://doi.org/10.1016/j.jclinepi.2011.02.003
State	Published - Aug 2011

Access to Document

10.1016/j.jclinepi.2011.02.003

Cite this

Janssens, A. C. J. W., Ioannidis, J. P. A., Bedrosian, S., Boffetta, P., Dolan, S. M., Dowling, N., Fortier, I., Freedman, A. N., Grimshaw, J. M., Gulcher, J., Gwinn, M., Hlatky, M. A., Janes, H., Kraft, P., Melillo, S., O'Donnell, C. J., Pencina, M. J., Ransohoff, D., Schully, S. D., ... Khoury, M. J. (2011). Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): Explanation and elaboration. Journal of Clinical Epidemiology, 64(8), e1-e22. https://doi.org/10.1016/j.jclinepi.2011.02.003

@article{83a9291f0969488ca37de2eace9500c9,

title = "Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): Explanation and elaboration",

author = "Janssens, {A. Cecile J.W.} and Ioannidis, {John P.A.} and Sara Bedrosian and Paolo Boffetta and Dolan, {Siobhan M.} and Nicole Dowling and Isabel Fortier and Freedman, {Andrew N.} and Grimshaw, {Jeremy M.} and Jeffrey Gulcher and Marta Gwinn and Hlatky, {Mark A.} and Holly Janes and Peter Kraft and Stephanie Melillo and O'Donnell, {Christopher J.} and Pencina, {Michael J.} and David Ransohoff and Schully, {Sheri D.} and Daniela Seminara and Winn, {Deborah M.} and Wright, {Caroline F.} and {Van Duijn}, {Cornelia M.} and Julian Little and Khoury, {Muin J.}",

note = "Funding Information: Examples. “This study was supported by grants from the National Heart, Lung, and Blood Institute and National Cancer Institute, National Institutes of Health; the Donald W. Reynolds Foundation; and the Leducq Foundation. Additional support for DNA extraction, reagents, and data analysis was provided by Roche Diagnostics and Amgen. Genotyping of the 9p21.3 variant was performed by Celera. The funding sources had no role in the design, conduct, or reporting of this study or the decision to submit the manuscript for publication.” [53] ",

year = "2011",

month = aug,

doi = "10.1016/j.jclinepi.2011.02.003",

language = "English",

volume = "64",

pages = "e1--e22",

journal = "Journal of Clinical Epidemiology",

issn = "0895-4356",

publisher = "Elsevier Inc.",

number = "8",

}

Janssens, ACJW, Ioannidis, JPA, Bedrosian, S, Boffetta, P, Dolan, SM, Dowling, N, Fortier, I, Freedman, AN, Grimshaw, JM, Gulcher, J, Gwinn, M, Hlatky, MA, Janes, H, Kraft, P, Melillo, S, O'Donnell, CJ, Pencina, MJ, Ransohoff, D, Schully, SD, Seminara, D, Winn, DM, Wright, CF, Van Duijn, CM, Little, J & Khoury, MJ 2011, 'Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): Explanation and elaboration', Journal of Clinical Epidemiology, vol. 64, no. 8, pp. e1-e22. https://doi.org/10.1016/j.jclinepi.2011.02.003

TY - JOUR

T1 - Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS)

T2 - Explanation and elaboration

AU - Janssens, A. Cecile J.W.

AU - Ioannidis, John P.A.

AU - Bedrosian, Sara

AU - Boffetta, Paolo

AU - Dolan, Siobhan M.

AU - Dowling, Nicole

AU - Fortier, Isabel

AU - Freedman, Andrew N.

AU - Grimshaw, Jeremy M.

AU - Gulcher, Jeffrey

AU - Gwinn, Marta

AU - Hlatky, Mark A.

AU - Janes, Holly

AU - Kraft, Peter

AU - Melillo, Stephanie

AU - O'Donnell, Christopher J.

AU - Pencina, Michael J.

AU - Ransohoff, David

AU - Schully, Sheri D.

AU - Seminara, Daniela

AU - Winn, Deborah M.

AU - Wright, Caroline F.

AU - Van Duijn, Cornelia M.

AU - Little, Julian

AU - Khoury, Muin J.

N1 - Funding Information: Examples. “This study was supported by grants from the National Heart, Lung, and Blood Institute and National Cancer Institute, National Institutes of Health; the Donald W. Reynolds Foundation; and the Leducq Foundation. Additional support for DNA extraction, reagents, and data analysis was provided by Roche Diagnostics and Amgen. Genotyping of the 9p21.3 variant was performed by Celera. The funding sources had no role in the design, conduct, or reporting of this study or the decision to submit the manuscript for publication.” [53]

PY - 2011/8

Y1 - 2011/8

UR - http://www.scopus.com/inward/record.url?scp=79959687158&partnerID=8YFLogxK

U2 - 10.1016/j.jclinepi.2011.02.003

DO - 10.1016/j.jclinepi.2011.02.003

M3 - Article

C2 - 21414753

AN - SCOPUS:79959687158

SN - 0895-4356

VL - 64

SP - e1-e22

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

IS - 8

ER -